{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:47:06Z","timestamp":1775886426291,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Science and Technology Base and Talent Project","award":["2019AC20357"],"award-info":[{"award-number":["2019AC20357"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32260166"],"award-info":[{"award-number":["32260166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06190-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:35:51Z","timestamp":1751380551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AGGF1-primed endothelial progenitor cells alleviate ischaemia-reperfusion injury in diabetic hearts"],"prefix":"10.1038","volume":"15","author":[{"given":"Xia","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suwan","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congcong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianqiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miaoling","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"6190_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.it.2022.12.004","volume":"44","author":"C Bleriot","year":"2023","unstructured":"Bleriot, C., Dalmas, E., Ginhoux, F. & Venteclef, N. Inflammatory and immune etiology of type 2 diabetes. Trends Immunol. 44, 101\u2013109. https:\/\/doi.org\/10.1016\/j.it.2022.12.004 (2023).","journal-title":"Trends Immunol."},{"key":"6190_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fendo.2017.00263","volume":"8","author":"K Menon","year":"2017","unstructured":"Menon, K. et al. Shared medical appointments May be effective for improving clinical and behavioral outcomes in type 2 diabetes: A narrative review. Front. Endocrinol. 8, 263\u2013274. https:\/\/doi.org\/10.3389\/fendo.2017.00263 (2017).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"6190_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ecl.2013.09.001","volume":"43","author":"MM Szuszkiewicz-Garcia","year":"2014","unstructured":"Szuszkiewicz-Garcia, M. M. & Davidson, J. A. Cardiovascular disease in diabetes mellitus: Risk factors and medical therapy. Endocrinol. Metab. Clin. 43, 25\u201340. https:\/\/doi.org\/10.1016\/j.ecl.2013.09.001 (2014).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"6190_CR4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.yjmcc.2019.04.015","volume":"131","author":"TW Hein","year":"2019","unstructured":"Hein, T. W. et al. Requisite roles of LOX-1, JNK, and arginase in diabetes-induced endothelial vasodilator dysfunction of Porcine coronary arterioles. J. Mol. Cell. Cardiol. 131, 82\u201390. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.04.015 (2019).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"6190_CR5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00059-022-05132-8","volume":"47","author":"F J Neumann","year":"2022","unstructured":"J. Neumann, F. Diabetes, heart failure, and myocardial revascularization: Is there a new message from the ISCHEMIA trial? Herz 47, 442\u2013448. https:\/\/doi.org\/10.1007\/s00059-022-05132-8 (2022).","journal-title":"Herz"},{"key":"6190_CR6","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.3390\/antiox9111108","volume":"9","author":"R Gal","year":"2020","unstructured":"Gal, R. et al. Resveratrol improves heart function by moderating inflammatory processes in patients with systolic heart failure. Antioxidants 9, 1108\u20131126. https:\/\/doi.org\/10.3390\/antiox9111108 (2020).","journal-title":"Antioxid. (Basel)"},{"key":"6190_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12964-023-01216-y","volume":"21","author":"Y Xiong","year":"2023","unstructured":"Xiong, Y. et al. Decreased MFN2 activates the cGAS-STING pathway in diabetic myocardial ischaemia-reperfusion by triggering the release of mitochondrial DNA. Cell. Commun. Signal. 21, 192\u2013213. https:\/\/doi.org\/10.1186\/s12964-023-01216-y (2023).","journal-title":"Cell. Commun. Signal."},{"key":"6190_CR8","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1007\/s00125-012-2594-1","volume":"55","author":"Y Chen","year":"2012","unstructured":"Chen, Y. et al. Activating transcription factor 4 mediates hyperglycaemia-induced endothelial inflammation and retinal vascular leakage through activation of STAT3 in a mouse model of type 1 diabetes. Diabetologia 55, 2533\u20132545. https:\/\/doi.org\/10.1007\/s00125-012-2594-1 (2012).","journal-title":"Diabetologia"},{"key":"6190_CR9","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1161\/circresaha.117.310619","volume":"120","author":"X Dai","year":"2017","unstructured":"Dai, X. et al. Elevating CXCR7 improves angiogenic function of EPCs via Akt\/GSK-3\u03b2\/Fyn-Mediated Nrf2 activation in diabetic limb ischemia. Circul. Res. 120, e7\u2013e23. https:\/\/doi.org\/10.1161\/circresaha.117.310619 (2017).","journal-title":"Circul. Res."},{"key":"6190_CR10","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.2337\/db18-1178","volume":"68","author":"Y Yao","year":"2019","unstructured":"Yao, Y. et al. Angiogenic factor AGGF1-Primed endothelial progenitor cells repair vascular defect in diabetic mice. Diabetes 68, 1635\u20131648. https:\/\/doi.org\/10.2337\/db18-1178 (2019).","journal-title":"Diabetes"},{"key":"6190_CR11","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1161\/01.cir.0000039526.42991.93","volume":"106","author":"OM Tepper","year":"2002","unstructured":"Tepper, O. M. et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106, 2781\u20132786. https:\/\/doi.org\/10.1161\/01.cir.0000039526.42991.93 (2002).","journal-title":"Circulation"},{"key":"6190_CR12","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1161\/circresaha.109.213140","volume":"106","author":"YP Jarajapu","year":"2010","unstructured":"Jarajapu, Y. P. & Grant, M. B. The promise of cell-based therapies for diabetic complications: Challenges and solutions. Circul. Res. 106, 854\u2013869. https:\/\/doi.org\/10.1161\/circresaha.109.213140 (2010).","journal-title":"Circul. Res."},{"key":"6190_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2015.12.020","volume":"91","author":"A Lejay","year":"2016","unstructured":"Lejay, A. et al. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus. J. Mol. Cell. Cardiol. 91, 11\u201322. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.12.020 (2016).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"6190_CR14","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/nature02320","volume":"427","author":"XL Tian","year":"2004","unstructured":"Tian, X. L. et al. Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome. Nature 427, 640\u2013645. https:\/\/doi.org\/10.1038\/nature02320 (2004).","journal-title":"Nature"},{"key":"6190_CR15","doi-asserted-by":"publisher","first-page":"e005889","DOI":"10.1161\/JAHA.117.005889","volume":"6","author":"Y Yao","year":"2017","unstructured":"Yao, Y. et al. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for blocking neointimal formation after vascular injury. J. Am. Heart Assoc. 6, e005889\u2013e005903. https:\/\/doi.org\/10.1161\/JAHA.117.005889 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"6190_CR16","doi-asserted-by":"publisher","first-page":"e1002529","DOI":"10.1371\/journal.pbio.1002529","volume":"14","author":"Q Lu","year":"2016","unstructured":"Lu, Q. et al. Angiogenic factor AGGF1 activates autophagy with an essential role in therapeutic angiogenesis for heart disease. PLoS Biol. 14, e1002529\u2013e1002558. https:\/\/doi.org\/10.1371\/journal.pbio.1002529 (2016).","journal-title":"PLoS Biol."},{"key":"6190_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41467-017-00171-w","volume":"8","author":"Y Yao","year":"2017","unstructured":"Yao, Y. et al. A non-canonical pathway regulates ER stress signaling and blocks ER stress-induced apoptosis and heart failure. Nat. Commun. 8, 133\u2013147. https:\/\/doi.org\/10.1038\/s41467-017-00171-w (2017).","journal-title":"Nat. Commun."},{"key":"6190_CR18","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1038\/s41467-023-37809-x","volume":"14","author":"X Da","year":"2023","unstructured":"Da, X. et al. AGGF1 therapy inhibits thoracic aortic aneurysms by enhancing integrin \u03b17-mediated Inhibition of TGF-\u03b21 maturation and ERK1\/2 signaling. Nat. Commun. 14, 2265\u20132283. https:\/\/doi.org\/10.1038\/s41467-023-37809-x (2023).","journal-title":"Nat. Commun."},{"key":"6190_CR19","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1002\/jcsm.13179","volume":"14","author":"Z He","year":"2023","unstructured":"He, Z. et al. Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1. J. Cachexia Sarcopenia Muscle 14, 978\u2013991. https:\/\/doi.org\/10.1002\/jcsm.13179 (2023).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"6190_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12974-018-1211-8","volume":"15","author":"Q Zhu","year":"2018","unstructured":"Zhu, Q. et al. Aggf1 attenuates neuroinflammation and BBB disruption via PI3K\/Akt\/NF-\u03baB pathway after subarachnoid hemorrhage in rats. J. Neuroinflamm. 15, 178\u2013190. https:\/\/doi.org\/10.1186\/s12974-018-1211-8 (2018).","journal-title":"J. Neuroinflamm."},{"key":"6190_CR21","doi-asserted-by":"publisher","unstructured":"Nagy, C. & Einwallner, E. Study of in vivo glucose metabolism in high-fat diet-fed mice using oral glucose tolerance test (OGTT) and insulin tolerance test (ITT). J. Vis. Exp. JoVE. https:\/\/doi.org\/10.3791\/56672 (2018).","DOI":"10.3791\/56672"},{"key":"6190_CR22","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1073\/pnas.97.7.3422","volume":"97","author":"C Kalka","year":"2000","unstructured":"Kalka, C. et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. U. S. A. 97, 3422\u20133427. https:\/\/doi.org\/10.1073\/pnas.97.7.3422 (2000).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"6190_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13287-021-02324-7","volume":"12","author":"C Jiang","year":"2021","unstructured":"Jiang, C. et al. Upregulating CXCR7 accelerates endothelial progenitor cell-mediated endothelial repair by activating Akt\/Keap-1\/Nrf2 signaling in diabetes mellitus. Stem Cell Res. Ther. 12, 264\u2013278. https:\/\/doi.org\/10.1186\/s13287-021-02324-7 (2021).","journal-title":"Stem Cell Res. Ther."},{"key":"6190_CR24","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3389\/fphar.2018.01213","volume":"9","author":"Y Yao","year":"2018","unstructured":"Yao, Y. et al. Losartan alleviates renal fibrosis and inhibits endothelial-to-mesenchymal transition (EMT) under high-fat diet-induced hyperglycemia. Front. Pharmacol. 9, 1213\u20131224. https:\/\/doi.org\/10.3389\/fphar.2018.01213 (2018).","journal-title":"Front. Pharmacol."},{"key":"6190_CR25","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401\u20132421. https:\/\/doi.org\/10.1016\/j.cell.2022.06.003 (2022).","journal-title":"Cell"},{"key":"6190_CR26","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/circulationaha.122.060257","volume":"147","author":"W Cai","year":"2023","unstructured":"Cai, W. et al. Alox15\/15-HpETE aggravates myocardial Ischemia-Reperfusion injury by promoting cardiomyocyte ferroptosis. Circulation 147, 1444\u20131460. https:\/\/doi.org\/10.1161\/circulationaha.122.060257 (2023).","journal-title":"Circulation"},{"key":"6190_CR27","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.7150\/thno.43895","volume":"11","author":"L Jiang","year":"2021","unstructured":"Jiang, L. et al. Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia\/reperfusion injury through inhibiting ROS production from mitochondrial complex I. Theranostics 11, 1703\u20131720. https:\/\/doi.org\/10.7150\/thno.43895 (2021).","journal-title":"Theranostics"},{"key":"6190_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1161\/circulationaha.111.049072","volume":"125","author":"A Galaup","year":"2012","unstructured":"Galaup, A. et al. Protection against myocardial infarction and no-reflow through preservation of vascular integrity by angiopoietin-like 4. Circulation 125, 140\u2013149. https:\/\/doi.org\/10.1161\/circulationaha.111.049072 (2012).","journal-title":"Circulation"},{"key":"6190_CR29","first-page":"B5054","volume":"62","author":"NL Halladin","year":"2015","unstructured":"Halladin, N. L. Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries. Dan. Med. J. 62, B5054\u2013B5075 (2015).","journal-title":"Dan. Med. J."},{"key":"6190_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13287-021-02266-0","volume":"12","author":"J Huang","year":"2021","unstructured":"Huang, J., Kong, Y., Xie, C. & Zhou, L. Stem\/progenitor cell in kidney: Characteristics, homing, coordination, and maintenance. Stem Cell. Res. Ther. 12, 197\u2013214. https:\/\/doi.org\/10.1186\/s13287-021-02266-0 (2021).","journal-title":"Stem Cell. Res. Ther."},{"key":"6190_CR31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41419-021-03693-w","volume":"12","author":"HM Chang","year":"2021","unstructured":"Chang, H. M. et al. FGF23 ameliorates ischemia-reperfusion induced acute kidney injury via modulation of endothelial progenitor cells: Targeting SDF-1\/CXCR4 signaling. Cell Death Dis. 12, 409\u2013427. https:\/\/doi.org\/10.1038\/s41419-021-03693-w (2021).","journal-title":"Cell Death Dis."},{"key":"6190_CR32","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1093\/hmg\/ddw273","volume":"25","author":"T Zhang","year":"2016","unstructured":"Zhang, T. et al. Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin. Hum. Mol. Genet. 25, 5094\u20135110. https:\/\/doi.org\/10.1093\/hmg\/ddw273 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"6190_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s40290-018-0261-7","volume":"33","author":"E Fisher","year":"2019","unstructured":"Fisher, E., Pavlenko, K., Vlasov, A. & Ramenskaya, G. Peptide-based therapeutics for oncology. Pharm. Med. 33, 9\u201320. https:\/\/doi.org\/10.1007\/s40290-018-0261-7 (2019).","journal-title":"Pharm. Med."},{"key":"6190_CR34","doi-asserted-by":"publisher","first-page":"101759","DOI":"10.1016\/j.jbc.2022.101759","volume":"298","author":"Y Yu","year":"2022","unstructured":"Yu, Y. et al. Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin \u03b17 on vascular smooth muscle cells. J. Biol. Chem. 298, 101759\u2013101773. https:\/\/doi.org\/10.1016\/j.jbc.2022.101759 (2022).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06190-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06190-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06190-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T14:35:52Z","timestamp":1751380552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06190-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6190"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06190-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5131412\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"22 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21803"}}